Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
24-Jan-21 | 227.00 | 26.00 | 22.31p | 21.8 | n/a | -16% | n/a | 0.0% |
30-Jan-22 | 268.60 | 42.20 | 21.59p | 23.0 | n/a | -3% | 12.00p | 2.4% |
29-Jan-23 | 317.60 | 44.40 | 29.66p | 17.7 | 0.5 | +37% | 13.10p | 2.5% |
28-Jan-24 | 400.00 | 51.30 | 33.88p | 16.3 | 1.2 | +14% | 15.05p | 2.7% |
25-Jan-25 | 420.40 | 53.20 | 39.77p | 14.6 | 0.9 | +17% | 16.86p | 2.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Jan-26 | 440.29 | 63.81 | 43.03p | 14.5 | 1.8 | +8% | 18.52p | 0.0% |
31-Jan-27 | 459.57 | 69.57 | 47.89p | 13.1 | 1.2 | +11% | 20.00p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 21.83 | 14.56 | 18.65 | 0.84 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 612.00p |
Change Today | -14.00p |
% Change | -2.24 % |
52 Week High | 668.00p |
52 Week Low | 549.00p |
Volume | 45,162 |
Shares Issued | 112.03m |
Market Cap | £685.62m |
RiskGrade | 132 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 5 |
Buy | 3 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 9 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 08-May-25 | 03-Oct-24 |
Paid | 06-Jun-25 | 01-Nov-24 |
Amount | 13.76p | 3.10p |
Time | Volume / Share Price |
15:02 | 29 @ 612.00p |
15:02 | 37 @ 612.00p |
15:02 | 38 @ 612.00p |
15:02 | 12 @ 613.00p |
15:02 | 24 @ 613.00p |
Finance Director | Stuart Lorimer |
CEO | Euan Sutherland |
You are here: research